Healthleap Raises $38M to Scale Clinical AI Platform
Healthleap raised $38M Seed and Series A led by Sequoia Capital to scale its clinical AI platform to prevent missed hospital diagnoses.
The big picture: San Francisco-based Healthleap announced a combined $38 million Seed and Series A funding round backed by Sequoia Capital, First Round Capital, and Hummingbird Ventures to scale a clinical AI platform designed to fix a systemic blind spot in hospital care.
Why it matters:
- Undiagnosed Conditions: US hospitals discharge thousands of patients with undiagnosed secondary conditions, leading to readmissions, poorer health outcomes, and increased costs down the road.
- Overwhelmed Clinicians: Busy clinical teams often miss critical risk factors due to time constraints and the complexity of sifting through extensive electronic health records (EHRs).
- Financial Impact: This oversight contributes to billions in annual costs for the U.S. healthcare system and reduces hospital revenue through missed reimbursements for treatable conditions like malnutrition.
How it works:
- Automated Safety Net: Healthleap’s AI continuously analyzes a patient’s entire EHR, including physician notes, vitals, and lab results, to proactively identify hidden risk factors for commonly missed conditions.
- Actionable Triage: Every morning, the platform generates an actionable triage list, directing care teams to specific patients who are exhibiting risk factors, ensuring timely intervention.
- Targeted Intervention: The platform initially focuses on disease-related malnutrition, a $58 billion crisis, and plans to expand its capabilities to detect early signs of congestive heart failure, hospital-acquired infections, and pressure ulcers.
The catch: While Healthleap addresses a critical need, the healthcare AI market is increasingly competitive, with many solutions vying for hospital budgets. Integrating new AI tools into existing, often complex, EHR systems without adding to ‘alert fatigue’ is a persistent challenge. Healthleap’s success hinges on its ability to demonstrate clear, measurable ROI beyond initial deployments and seamlessly integrate into clinician workflows across diverse health systems.
Key Facts
- Company: Healthleap
- Amount: $38M
- Round: Seed and Series A
- Investors: Sequoia Capital (lead), First Round Capital, Hummingbird Ventures
- Founders: Josiah Meyer, Jemima Meyer
- Sector: Clinical AI Platform
- Headquarters: San Francisco, US
Funding Weekly
Every AI funding round we reported last week: the totals, the biggest deals and what they add up to. Weekly · Tuesdays.